Biological dynamics of hepatitis B virus load in dialysis population

American Journal of Kidney Diseases

Volumn 41, Issue 6, 2003, Pages 1278-1285

  Fabrizi, Fabrizio ^a   Lunghi, Giovanna ^b   Alongi, Giancarlo ^b   Bisegna, Sergio ^b   Campolo, Gesualdo ^b   Mangano, Stefano ^b   Limido, Aurelio ^b   Pagliari, Bruno ^b   Tettamanzi, Fabio ^b   Ponticelli, Claudio ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE

Author keywords

Chronic hepatitis B virus (HBV) infection; Dialysis; Fluctuations; Hepatitis B virus viremia (HBV DNA)

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BIOLOGY; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; DNA DETERMINATION; DNA HYBRIDIZATION; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; POPULATION DYNAMICS; QUANTITATIVE ASSAY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TIME; VIREMIA; VIRUS INFECTION; VIRUS LOAD;

EID: 12444333590     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00360-3     Document Type: Article

References (33)

1. Tokars JI, Frank M, Alter MJ, Arduino MJ: National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 15:162-171, 2002
2. Kellerman S, Alter MJ: Preventing hepatitis B and C virus infections in end-stage renal disease patients: Back to basics. Hepatology 29:291-293, 1999
3. Centers for Disease Control and Prevention: Outbreaks of hepatitis B virus infection among hemodialysis patients - California, Nebraska, and Texas, 1994. JAMA 275:1394-1395, 1996
4. Hutin YJF, Goldstein ST, Varma JK, et al: An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 20:731-735, 1999
5. Covic A, Iancu L, Apetrei C, et al: Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 14:40-45, 1999
6. Lewis-Ximenez LL, Oliveira JM, Mercadante LAC, et al: Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron 87:19-26, 2001
7. Cendoroglo Neto M, Draibe SA, Silva AEB, et al: Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: Evidence for environmental transmission. Nephrol Dial Transplant 10:240-246, 1995
8. Vladutiu D, Cosa A, Neamtu A, et al: Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: Yellow spots on a blank map? J Viral Hepat 7:313-319, 2000
9. Jankovic N, Cala S, Nadinic B, Varlai-Knobloch V, Pavlovic D: Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: A two year follow-up. Int J Artif Organs 17:137-140, 1994
10. Jaiswal SP, Chitnis DS, Salgia P, Sepaha A, Pandit CS: Prevalence of hepatitis viruses among chronic renal failure patients on hemodialysis in central India. Dial Transplant 31:234-240, 2002
11. Pao CC, Yang WL, Huang CC, et al: Hepatitis type B virus DNA in patients receiving hemodialysis: Correlation with other HBV serological markers. Nephron 46:155-160, 1987
12. Dueymes JM, Bodenes-Dueymes M, Mahè JL, Herman B: Detection of hepatitis B viral DNA by polymerase chain reaction in dialysis patients. Kidney Int Suppl 41:S161-S166, 1993
13. Oesterreicher C, Hammer J, Koch U, et al: HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 48: 1967-1971, 1995
14. Cabrerizo M, Bartolomè J, De Sequera P, Caramelo C, Carreno V: Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol 8:1443-1447, 1997
15. Cabrerizo M, Bartolomè J, Caramelo C, Barril G, Carreno V: Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 32:116-123, 2000
16. Roche Diagnostics: Amplicor HBV Monitor™ Test Kit package insert. Branchburg, NJ, Roche Diagnostics, 1999
17. Lòpez-Alcorocho JM, Cabrerizo M, Bartolomè J, Cotonat T, Carreno V: Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon. J Viral Hepat 2:279-284, 1995
18. Kohler H: Hepatitis B immunization in dialysis patients - Is it worthwhile? Nephrol Dial Transplant 9:1719-1720, 1994
19. Gimdt M, Kohler H: Hepatitis B virus infection in hemodialysis patients. Semin Nephrol 22:340-350, 2002
20. Salo JR, Salo AA, Fahlberg WJ, Ellzey JT: Hepatitis B surface antigen (HBsAg) in peritoneal fluid of HBsAg carriers undergoing peritoneal dialysis. J Med Virol 6:29-35, 1980
21. Kroes ACM, van Bommel EFH, Niesters HGM, Weimar W: Hepatitis B viral DNA detectable in dialysate. Nephron 67:369, 1994 (letter)
22. Moynot A, Lazizi Y, Dubreuil P, Buisson C, Pillot J: Nature of HBsAg ultrafiltrate of haemodialysed patients: Presence of viral DNA. Nephrol Dial Transplant 49:88, 1988 (letter)
23. Rostaing L, Chatelut E, Payen JL, et al: Pharmacokinetics of αIFN-2b in chronic hepatitis C virus undergoing chronic hemodialysis or with normal renal function: Clinical implications. J Am Soc Nephrol 9:2344-2348, 1998
24. Graziani G, Badalamenti S, Sampietro M, et al: Produzione endogena di α-interferone (α-IFN) durante emodialisi in pazienti HCV positivi. G Ital Nefrolog 15:S191A, 1998 (suppl 10; abstr)
25. Fabrizi F, Lunghi G, Martin P: Hepatitis B virus infection in hemodialysis: Recent discoveries. J Nephrol 15:1-7, 2002
26. Guh JY, Lai YH, Yang CY, et al: Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 69:459-465, 1995
27. Hung KY, Lee KC, Yen CJ, Wu KD, Tsai TJ, Chen WY: Revised cut-off values of serum aminotransferase in detecting viral hepatitis among CAPD patients: Experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 12:180-183, 1997
28. Yasuda K, Okuda K, Endo N, et al: Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology 109: 1295-1300, 1995
29. Fabrizi F, Lunghi G, Finazzi S, et al: Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis. Am J Kidney Dis 38:1009-1015, 2001
30. Yang H-I, Lu S-N, Liaw Y-F, et al: Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347:168-174, 2002
31. Liang TJ, Ghany M: Hepatitis B e antigen - The dangerous endgame of hepatitis B. N Engl J Med 347:208-210, 2002
32. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH: Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 67:823-832, 1993
33. Villa E, Grottola A, Trande P, et al: Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, anti-HCV positive patients. Lancet 341: 1414, 1993 (letter)